International Journal of Hematology-Oncology and Stem Cell Research 2017. 11(3):172-177.

Patterns of DNMT1 Promoter Methylation in Patients with Acute Lymphoblastic Leukemia
Tirdad Rahmani, Mehdi Azad, Bahram Chahardouli, Hajar Nasiri, Mousa Vatanmakanian, Saeid Kaviani


Background: Acute lymphoblastic leukemia (ALL) is a clonal malignant disorder characterized by an uncontrolled proliferation of immature T or B lymphocytes. Extensive studies have shown that the epigenetic changes, especially modified DNA methylation patterns in the regulatory regions through the DNA methyltransferase (DNMTs), play an important role in the development of genetic disorders and abnormal growth and maturation capacity of leukemic stem cells (LSCs).The aim of this study was to evaluate the changes in DNMT1 promoter methylation and its expression pattern in patients with ALL.

Subjects and Methods: In this experimental study, methylation specific PCR (MSP) was used to assess the methylation status of DNMT1 promoter regions in samples collected from ALL patients (n=45) and healthy control subjects. According to this method, un-methylated cytosine nucleotides are converted to uracil by sodium bisulfite and the proliferation of methylated and un-methylated regions are performed using specific primers for target sequences.

Results: None of the patients with B and T-ALL showed methylated promoter regions of the DNMT1 gene, while the methylation pattern of both pre-B ALL patients and the control group showed a relative promoter methylation.

Conclusion: Analysis of promoter methylation patterns in various subgroups of ALL has revealed the importance of DNMT1 in the regulation of gene expression. Likewise, extensive data have also highlighted the methylation-based mechanisms exerted by DNAM1 as one of the main participants regulating gene expression in B-ALL and T-ALL patients. Investigation of the overall DNA methylation pattern offers significant improvements in the prediction of disease prognosis and treatment response.


Acute lymphocytic leukemia, Epigenetic, Methylation, DNA methyltransferase

Full Text:



Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013; 381(9881):1943-55.

Florean C, Schnekenburger M, Grandjenette C, et al. Epigenomics of leukemia: from mechanisms to therapeutic applications. Epigenomics. 2011; 3(5):581-609.

Jiang Y, Hatzi K, Shaknovich R. Mechanisms of epigenetic deregulation in lymphoid neoplasms. Blood. 2013; 121(21):4271-9.

Jin B, Robertson KD. DNA methyltransferases, DNA damage repair, and cancer. Epigenetic Alterations in Oncogenesis: Springer. 2013.724: 3-29.

Azad M, Kaviani S, Noruzinia M, et al. Gene Expression Status and Methylation Pattern in Promoter of P15INK4b and P16INK4a in Cord Blood CD34 (+) Stem Cells. IranJBasic Med Sci. 2013; 16(7):822-8.

Trowbridge JJ, Sinha AU, Armstrong SA, et al. Haploinsufficiency of Dnmt1 Impairs Leukemia Stem Cell Function Through Derepression of Bivalent Chromatin Domains.Genes Dev. 2012. 26(4): 344-9.

Nordlund J, Bäcklin CL, Wahlberg P, et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 2013; 14(9):r105.

Van Otterdijk SD, Norden J, Dickinson AM, et al. Aberrations in DNA methylation are detectable during remission of acute lymphoblastic leukemia and predict patient outcome. Epigenomics. 2015; 7(1):35-45.

Azad M, Bakhshi Biniaz R, Goudarzi M, et al. Short view of leukemia diagnosis and treatment in Iran. Int JHematoL Oncol Stem Cell Res. 2015; 9(2):88-94.

Zhao X, Zhang W, Wang L, et al. Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy. Biomarker Res. 2013; 1(1):24.

Li D, Bi FF, Cao JM, et al. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation. Mol Cancer. 2014; 13(1):26.

Ikawa T. Genetic and epigenetic control of early lymphocyte development. Transcriptional Control of Lineage Differentiation in Immune Cells: Springer; 2014; 381: 1-20.

Shaknovich R, Cerchietti L, Tsikitas L, et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood. 2011; 118(13):3559-69.

Shaknovich R, Melnick A. Epigenetics and B-cell lymphoma. Curr OpinHematol. 2011; 18(4):293-9.

Lee PP, Fitzpatrick DR, Beard C, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 2001; 15(5):763-74.

Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012; 12(3):180-90.

Gasteiger G, Kastenmuller W. Foxp3+ regulatory T-cells and IL-2: the Moirai of T-cell fates? The Molecular Mechanisms of Regulatory T cell Immunosuppression. Front Immunol. 2012; 3:179.

Mizuno Si, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001; 97(5):1172-9.

Trowbridge JJ, Orkin SH. DNA methylation in adult stem cells: New insights into self-renewal. Epigenetics. 2010; 5(3):189-93.

Sahmani M, Vatanmakanian M, Goudarzi M, et al. Microchips and their Significance in Isolation of Circulating Tumor Cells and Monitoring of Cancers. Asian Pacific JCancer Prevent. 2016; 17(3):879-94.

Bröske AM, Vockentanz L, Kharazi S, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet.2009; 41(11):1207-15.

Wagner W, Saffrich R, Wirkner U, et al. Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction. Stem Cells. 2005;23(8):1180-91.

Ciccarone F, Malavolta M, Calabrese R, et al. Age-dependent expression of DNMT1 and DNMT3B in PBMCs from a large European population enrolled in the MARK-AGE study. Aging Cell. 2016; 15(4):755-65.

Wong NC, Ashley D, Chatterton Z, et al. A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia. Epigenetics. 2012; 7(6):535-41.

Jin Y, Wang X, Hu S, et al. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing. Cancer Med. 2016; 5(2):337-51.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.